nodes	percent_of_prediction	percent_of_DWPC	metapath
Sofosbuvir—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.11	0.514	CbGbCtD
Sofosbuvir—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.104	0.486	CbGbCtD
Sofosbuvir—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00469	0.00597	CcSEcCtD
Sofosbuvir—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00463	0.00589	CcSEcCtD
Sofosbuvir—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00458	0.00584	CcSEcCtD
Sofosbuvir—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00456	0.0058	CcSEcCtD
Sofosbuvir—Migraine—Salbutamol—chronic obstructive pulmonary disease	0.00453	0.00577	CcSEcCtD
Sofosbuvir—Dry skin—Arformoterol—chronic obstructive pulmonary disease	0.00447	0.00569	CcSEcCtD
Sofosbuvir—Dry skin—Formoterol—chronic obstructive pulmonary disease	0.00447	0.00569	CcSEcCtD
Sofosbuvir—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00439	0.00559	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Arformoterol—chronic obstructive pulmonary disease	0.00436	0.00555	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Formoterol—chronic obstructive pulmonary disease	0.00436	0.00555	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Roflumilast—chronic obstructive pulmonary disease	0.0043	0.00548	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Montelukast—chronic obstructive pulmonary disease	0.00427	0.00544	CcSEcCtD
Sofosbuvir—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00427	0.00544	CcSEcCtD
Sofosbuvir—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.00415	0.00529	CcSEcCtD
Sofosbuvir—Nasopharyngitis—Salbutamol—chronic obstructive pulmonary disease	0.00412	0.00524	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00411	0.00523	CcSEcCtD
Sofosbuvir—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.0041	0.00522	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00408	0.00519	CcSEcCtD
Sofosbuvir—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00407	0.00518	CcSEcCtD
Sofosbuvir—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00404	0.00514	CcSEcCtD
Sofosbuvir—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.00392	0.00498	CcSEcCtD
Sofosbuvir—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.0039	0.00497	CcSEcCtD
Sofosbuvir—Suicidal ideation—Prednisone—chronic obstructive pulmonary disease	0.00377	0.0048	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00377	0.00479	CcSEcCtD
Sofosbuvir—Infestation NOS—Montelukast—chronic obstructive pulmonary disease	0.00368	0.00468	CcSEcCtD
Sofosbuvir—Infestation—Montelukast—chronic obstructive pulmonary disease	0.00368	0.00468	CcSEcCtD
Sofosbuvir—Malnutrition—Tiotropium—chronic obstructive pulmonary disease	0.00364	0.00463	CcSEcCtD
Sofosbuvir—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00354	0.00451	CcSEcCtD
Sofosbuvir—Back pain—Tiotropium—chronic obstructive pulmonary disease	0.00352	0.00448	CcSEcCtD
Sofosbuvir—Hepatobiliary disease—Montelukast—chronic obstructive pulmonary disease	0.00348	0.00443	CcSEcCtD
Sofosbuvir—Vision blurred—Tiotropium—chronic obstructive pulmonary disease	0.00343	0.00436	CcSEcCtD
Sofosbuvir—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00339	0.00431	CcSEcCtD
Sofosbuvir—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.00337	0.00429	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00331	0.00422	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00331	0.00422	CcSEcCtD
Sofosbuvir—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00327	0.00417	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00325	0.00413	CcSEcCtD
Sofosbuvir—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00323	0.00411	CcSEcCtD
Sofosbuvir—Cough—Tiotropium—chronic obstructive pulmonary disease	0.00317	0.00404	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00313	0.00398	CcSEcCtD
Sofosbuvir—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00313	0.00398	CcSEcCtD
Sofosbuvir—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00312	0.00397	CcSEcCtD
Sofosbuvir—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.0031	0.00394	CcSEcCtD
Sofosbuvir—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.0031	0.00394	CcSEcCtD
Sofosbuvir—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.0031	0.00394	CcSEcCtD
Sofosbuvir—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00309	0.00393	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00308	0.00392	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00304	0.00387	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00304	0.00387	CcSEcCtD
Sofosbuvir—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00303	0.00386	CcSEcCtD
Sofosbuvir—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.003	0.00382	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00298	0.00379	CcSEcCtD
Sofosbuvir—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00298	0.00379	CcSEcCtD
Sofosbuvir—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00297	0.00379	CcSEcCtD
Sofosbuvir—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00296	0.00376	CcSEcCtD
Sofosbuvir—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00295	0.00375	CcSEcCtD
Sofosbuvir—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00294	0.00374	CcSEcCtD
Sofosbuvir—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00294	0.00374	CcSEcCtD
Sofosbuvir—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00291	0.00371	CcSEcCtD
Sofosbuvir—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00288	0.00367	CcSEcCtD
Sofosbuvir—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00287	0.00365	CcSEcCtD
Sofosbuvir—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00286	0.00364	CcSEcCtD
Sofosbuvir—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00285	0.00362	CcSEcCtD
Sofosbuvir—Back pain—Formoterol—chronic obstructive pulmonary disease	0.00284	0.00362	CcSEcCtD
Sofosbuvir—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.00284	0.00362	CcSEcCtD
Sofosbuvir—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.00282	0.00359	CcSEcCtD
Sofosbuvir—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.00282	0.00359	CcSEcCtD
Sofosbuvir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0028	0.00357	CcSEcCtD
Sofosbuvir—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00277	0.00353	CcSEcCtD
Sofosbuvir—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00277	0.00353	CcSEcCtD
Sofosbuvir—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.00276	0.00352	CcSEcCtD
Sofosbuvir—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00274	0.00348	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.0027	0.00344	CcSEcCtD
Sofosbuvir—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.0027	0.00343	CcSEcCtD
Sofosbuvir—Agitation—Formoterol—chronic obstructive pulmonary disease	0.0027	0.00343	CcSEcCtD
Sofosbuvir—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00268	0.00342	CcSEcCtD
Sofosbuvir—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.00268	0.00341	CcSEcCtD
Sofosbuvir—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.00266	0.00339	CcSEcCtD
Sofosbuvir—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00264	0.00336	CcSEcCtD
Sofosbuvir—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00261	0.00333	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00256	0.00326	CcSEcCtD
Sofosbuvir—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00326	CcSEcCtD
Sofosbuvir—Cough—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00326	CcSEcCtD
Sofosbuvir—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00324	CcSEcCtD
Sofosbuvir—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00254	0.00323	CcSEcCtD
Sofosbuvir—Cough—Montelukast—chronic obstructive pulmonary disease	0.00251	0.00319	CcSEcCtD
Sofosbuvir—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0025	0.00318	CcSEcCtD
Sofosbuvir—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0025	0.00318	CcSEcCtD
Sofosbuvir—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0025	0.00318	CcSEcCtD
Sofosbuvir—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0025	0.00318	CcSEcCtD
Sofosbuvir—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0025	0.00318	CcSEcCtD
Sofosbuvir—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0025	0.00318	CcSEcCtD
Sofosbuvir—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00249	0.00317	CcSEcCtD
Sofosbuvir—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00249	0.00317	CcSEcCtD
Sofosbuvir—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00249	0.00317	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00248	0.00316	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00248	0.00316	CcSEcCtD
Sofosbuvir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00245	0.00312	CcSEcCtD
Sofosbuvir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00245	0.00312	CcSEcCtD
Sofosbuvir—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00244	0.00311	CcSEcCtD
Sofosbuvir—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00244	0.00311	CcSEcCtD
Sofosbuvir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00311	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00243	0.0031	CcSEcCtD
Sofosbuvir—Dry skin—Prednisolone—chronic obstructive pulmonary disease	0.00242	0.00308	CcSEcCtD
Sofosbuvir—Cough—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.00308	CcSEcCtD
Sofosbuvir—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00303	CcSEcCtD
Sofosbuvir—Infection—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00303	CcSEcCtD
Sofosbuvir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.003	CcSEcCtD
Sofosbuvir—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.003	CcSEcCtD
Sofosbuvir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00236	0.003	CcSEcCtD
Sofosbuvir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00299	CcSEcCtD
Sofosbuvir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00299	CcSEcCtD
Sofosbuvir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00299	CcSEcCtD
Sofosbuvir—Infection—Montelukast—chronic obstructive pulmonary disease	0.00233	0.00297	CcSEcCtD
Sofosbuvir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00233	0.00296	CcSEcCtD
Sofosbuvir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00233	0.00296	CcSEcCtD
Sofosbuvir—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00231	0.00294	CcSEcCtD
Sofosbuvir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.0023	0.00293	CcSEcCtD
Sofosbuvir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00228	0.0029	CcSEcCtD
Sofosbuvir—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00225	0.00286	CcSEcCtD
Sofosbuvir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.00284	CcSEcCtD
Sofosbuvir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00282	CcSEcCtD
Sofosbuvir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.0022	0.0028	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00218	0.00278	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00218	0.00278	CcSEcCtD
Sofosbuvir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00217	0.00276	CcSEcCtD
Sofosbuvir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00217	0.00276	CcSEcCtD
Sofosbuvir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00215	0.00274	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00214	0.00272	CcSEcCtD
Sofosbuvir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00214	0.00272	CcSEcCtD
Sofosbuvir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00214	0.00272	CcSEcCtD
Sofosbuvir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00212	0.0027	CcSEcCtD
Sofosbuvir—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00211	0.00268	CcSEcCtD
Sofosbuvir—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00211	0.00268	CcSEcCtD
Sofosbuvir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.0021	0.00267	CcSEcCtD
Sofosbuvir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00208	0.00265	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00263	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00263	CcSEcCtD
Sofosbuvir—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00207	0.00263	CcSEcCtD
Sofosbuvir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00263	CcSEcCtD
Sofosbuvir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00263	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00262	CcSEcCtD
Sofosbuvir—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00261	CcSEcCtD
Sofosbuvir—Pain—Formoterol—chronic obstructive pulmonary disease	0.00205	0.00261	CcSEcCtD
Sofosbuvir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00261	CcSEcCtD
Sofosbuvir—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00205	0.00261	CcSEcCtD
Sofosbuvir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00205	0.0026	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00203	0.00258	CcSEcCtD
Sofosbuvir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00202	0.00258	CcSEcCtD
Sofosbuvir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00202	0.00257	CcSEcCtD
Sofosbuvir—Pain—Montelukast—chronic obstructive pulmonary disease	0.00201	0.00255	CcSEcCtD
Sofosbuvir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.002	0.00255	CcSEcCtD
Sofosbuvir—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00199	0.00254	CcSEcCtD
Sofosbuvir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00253	CcSEcCtD
Sofosbuvir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00198	0.00252	CcSEcCtD
Sofosbuvir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00197	0.00251	CcSEcCtD
Sofosbuvir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00197	0.0025	CcSEcCtD
Sofosbuvir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00196	0.0025	CcSEcCtD
Sofosbuvir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00249	CcSEcCtD
Sofosbuvir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.00248	CcSEcCtD
Sofosbuvir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00246	CcSEcCtD
Sofosbuvir—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00246	CcSEcCtD
Sofosbuvir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00189	0.00241	CcSEcCtD
Sofosbuvir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00189	0.00241	CcSEcCtD
Sofosbuvir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00189	0.0024	CcSEcCtD
Sofosbuvir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.00238	CcSEcCtD
Sofosbuvir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00187	0.00238	CcSEcCtD
Sofosbuvir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00187	0.00238	CcSEcCtD
Sofosbuvir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00186	0.00237	CcSEcCtD
Sofosbuvir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00185	0.00236	CcSEcCtD
Sofosbuvir—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00183	0.00233	CcSEcCtD
Sofosbuvir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00228	CcSEcCtD
Sofosbuvir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00224	CcSEcCtD
Sofosbuvir—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.00176	0.00224	CcSEcCtD
Sofosbuvir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00219	CcSEcCtD
Sofosbuvir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00219	CcSEcCtD
Sofosbuvir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00216	CcSEcCtD
Sofosbuvir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00216	CcSEcCtD
Sofosbuvir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00214	CcSEcCtD
Sofosbuvir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00166	0.00211	CcSEcCtD
Sofosbuvir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00164	0.00209	CcSEcCtD
Sofosbuvir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00164	0.00209	CcSEcCtD
Sofosbuvir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00207	CcSEcCtD
Sofosbuvir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00161	0.00204	CcSEcCtD
Sofosbuvir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00204	CcSEcCtD
Sofosbuvir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00158	0.00202	CcSEcCtD
Sofosbuvir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00158	0.00202	CcSEcCtD
Sofosbuvir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00198	CcSEcCtD
Sofosbuvir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.00155	0.00197	CcSEcCtD
Sofosbuvir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00197	CcSEcCtD
Sofosbuvir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00152	0.00194	CcSEcCtD
Sofosbuvir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00152	0.00194	CcSEcCtD
Sofosbuvir—Rash—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00192	CcSEcCtD
Sofosbuvir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00192	CcSEcCtD
Sofosbuvir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00192	CcSEcCtD
Sofosbuvir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00192	CcSEcCtD
Sofosbuvir—Headache—Formoterol—chronic obstructive pulmonary disease	0.0015	0.00191	CcSEcCtD
Sofosbuvir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.0015	0.00191	CcSEcCtD
Sofosbuvir—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.0015	0.00191	CcSEcCtD
Sofosbuvir—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.0015	0.00191	CcSEcCtD
Sofosbuvir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.0019	CcSEcCtD
Sofosbuvir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00149	0.0019	CcSEcCtD
Sofosbuvir—Rash—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00188	CcSEcCtD
Sofosbuvir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00188	CcSEcCtD
Sofosbuvir—Headache—Montelukast—chronic obstructive pulmonary disease	0.00147	0.00187	CcSEcCtD
Sofosbuvir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00144	0.00183	CcSEcCtD
Sofosbuvir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00182	CcSEcCtD
Sofosbuvir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.00181	CcSEcCtD
Sofosbuvir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00142	0.00181	CcSEcCtD
Sofosbuvir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.00181	CcSEcCtD
Sofosbuvir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00142	0.0018	CcSEcCtD
Sofosbuvir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00139	0.00177	CcSEcCtD
Sofosbuvir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00171	CcSEcCtD
Sofosbuvir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.0013	0.00166	CcSEcCtD
Sofosbuvir—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00124	0.00158	CcSEcCtD
Sofosbuvir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00117	0.00149	CcSEcCtD
Sofosbuvir—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00117	0.00149	CcSEcCtD
Sofosbuvir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00116	0.00147	CcSEcCtD
Sofosbuvir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00141	CcSEcCtD
Sofosbuvir—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00139	CcSEcCtD
Sofosbuvir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00136	CcSEcCtD
Sofosbuvir—Agitation—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00135	CcSEcCtD
Sofosbuvir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000983	0.00125	CcSEcCtD
Sofosbuvir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000983	0.00125	CcSEcCtD
Sofosbuvir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00098	0.00125	CcSEcCtD
Sofosbuvir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000977	0.00124	CcSEcCtD
Sofosbuvir—Infection—Prednisone—chronic obstructive pulmonary disease	0.000937	0.00119	CcSEcCtD
Sofosbuvir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000925	0.00118	CcSEcCtD
Sofosbuvir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000916	0.00117	CcSEcCtD
Sofosbuvir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000859	0.00109	CcSEcCtD
Sofosbuvir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000858	0.00109	CcSEcCtD
Sofosbuvir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000853	0.00109	CcSEcCtD
Sofosbuvir—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.00083	0.00106	CcSEcCtD
Sofosbuvir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00082	0.00104	CcSEcCtD
Sofosbuvir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000818	0.00104	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000817	0.00104	CcSEcCtD
Sofosbuvir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000813	0.00103	CcSEcCtD
Sofosbuvir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000813	0.00103	CcSEcCtD
Sofosbuvir—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000806	0.00103	CcSEcCtD
Sofosbuvir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000771	0.000981	CcSEcCtD
Sofosbuvir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000745	0.000949	CcSEcCtD
Sofosbuvir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000676	0.000861	CcSEcCtD
Sofosbuvir—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000667	0.000849	CcSEcCtD
Sofosbuvir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000645	0.000821	CcSEcCtD
Sofosbuvir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000623	0.000794	CcSEcCtD
Sofosbuvir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000599	0.000763	CcSEcCtD
Sofosbuvir—Rash—Prednisone—chronic obstructive pulmonary disease	0.000594	0.000757	CcSEcCtD
Sofosbuvir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000594	0.000756	CcSEcCtD
Sofosbuvir—Headache—Prednisone—chronic obstructive pulmonary disease	0.000591	0.000752	CcSEcCtD
Sofosbuvir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00056	0.000713	CcSEcCtD
